[{"data": {"name": "SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer", "@type": "ScholarlyArticle", "genre": "journal-article", "author": [{"name": "Z. A. Nahleh", "@type": "Person"}, {"name": "W. E. Barlow", "@type": "Person"}, {"name": "D. F. Hayes", "@type": "Person"}, {"name": "A. F. Schott", "@type": "Person"}, {"name": "J. R. Gralow", "@type": "Person"}, {"name": "W. M. Sikov", "@type": "Person"}, {"name": "E. A. Perez", "@type": "Person"}, {"name": "S. Chennuru", "@type": "Person"}, {"name": "H. R. Mirshahidi", "@type": "Person"}, {"name": "S. W. Corso", "@type": "Person"}, {"name": "D. L. Lew", "@type": "Person"}, {"name": "L. Pusztai", "@type": "Person"}, {"name": "R. B. Livingston", "@type": "Person"}, {"name": "G. N. Hortobagyi", "@type": "Person"}], "license": "cc-by-nc", "@context": "http://schema.org/", "encoding": [{"@type": "MediaObject", "contentUrl": "https://link.springer.com/content/pdf/10.1007%2Fs10549-016-3889-6.pdf", "encodingFormat": "application/pdf"}, {"@type": "MediaObject", "contentUrl": "http://europepmc.org/articles/pmc4963434?pdf=render", "encodingFormat": "application/pdf"}], "publisher": {"name": "Springer Nature", "@type": "Organization"}, "identifier": [{"@type": "PropertyValue", "value": "10.1007/s10549-016-3889-6", "propertyID": "DOI"}, {"@type": "PropertyValue", "value": "CC8jihk4NwfPb-CTiYzSatJzr8N-CDGfv7jdCFRG7-CRDmGkLQo8eJD", "propertyID": "ISCC"}], "datePublished": "2016-07-08"}, "schema": "schema.org", "mediatype": "application/ld+json"}]